Literature DB >> 6134543

Development of tolerance and cross-tolerance to the psychomotor actions of lorazepam and diazepam in man.

K Aranko, M J Mattila, T Seppälä.   

Abstract

1 Development of tolerance and cross-tolerance to lorazepam and diazepam in man was assessed in a double-blind and cross-over trial where eight pretrained healthy students volunteered for four 1 week treatment periods started at 1 month intervals. 2 In each period acute psychomotor responses to oral lorazepam 3 mg and diazepam 15 mg were recorded on day 1, as well as on day 8 after 1 week's treatment twice daily with diazepam 5 mg, lorazepam 1 mg, and placebo. At each session several objective psychomotor tests and subjective assessments were done before the drug intake and 1, 2.5, and 4 h after it. 3 In general, the effects of lorazepam were stronger and of longer duration than those of diazepam at the doses used. When comparing the single-dose responses on days 1 and 8, tolerance to lorazepam effects and some cross-tolerance developed on several functions measured. Tolerance but not cross-tolerance developed on choice reaction errors whereas the opposite was found on flicker fusion. No definite tolerance was found on subjective effects. 4 The results tally with an assumption that tolerance to benzodiazepine actions develops at different rates on various parameters measured.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6134543      PMCID: PMC1427709          DOI: 10.1111/j.1365-2125.1983.tb02088.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  22 in total

1.  Mood and performance of poor sleepers during repeated use of flurazepam.

Authors:  M W Church; L C Johnson
Journal:  Psychopharmacology (Berl)       Date:  1979-03-28       Impact factor: 4.530

2.  Residual effects and skills related to driving after a single oral administration of diazepam, medazepam or lorazepam.

Authors:  K Seppälä; K Korttila; S Häkkinen; M Linnoila
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

3.  Effects of m-xylene on human equilibrium measured with a quantitative method.

Authors:  K Savolainen; M Linnavuo
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1979-04

4.  Increase of "antianxiety" activity and tolerance of behavioral depression during chronic administration of oxazepam.

Authors:  D L Margules; L Stein
Journal:  Psychopharmacologia       Date:  1968

5.  The two-period cross-over clinical trial.

Authors:  M Hills; P Armitage
Journal:  Br J Clin Pharmacol       Date:  1979-07       Impact factor: 4.335

6.  Visual analogue scales.

Authors:  D F Stubbs
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

7.  Radiohistochemical localization of benzodiazepine receptors in rat brain.

Authors:  W S Young; M J Kuhar
Journal:  J Pharmacol Exp Ther       Date:  1980-02       Impact factor: 4.030

8.  Acute effects of temazepam and nitrazepam on psychomotor skills and memory.

Authors:  R Liljequist; M J Mattila
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1979-05

9.  Effect of active metabolites of chlordiazepoxide and diazepam, alone or in combination with alcohol, on psychomotor skills related to driving.

Authors:  E S Palva; M Linnoila
Journal:  Eur J Clin Pharmacol       Date:  1978-07-30       Impact factor: 2.953

10.  Measurement of recovery from outpatient general anaesthesia with a simple ocular test.

Authors:  J G Hannington-Kiff
Journal:  Br Med J       Date:  1970-07-18
View more
  13 in total

1.  Effect on postural sway of various benzodiazepine tranquillizers.

Authors:  A Patat; P Foulhoux
Journal:  Br J Clin Pharmacol       Date:  1985-07       Impact factor: 4.335

2.  Dose tolerance to lorazepam develop with once weekly dosing?

Authors:  S E File; R G Lister
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

3.  Influence of dosing regimen on alprazolam and metabolite serum concentrations and tolerance to sedative and psychomotor effects.

Authors:  R B Smith; P D Kroboth
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Interaction of diazepam or lorazepam with alcohol. Psychomotor effects and bioassayed serum levels after single and repeated doses.

Authors:  K Aranko; T Seppälä; J Pellinen; M J Mattila
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 5.  Residual effects of hypnotics: epidemiology and clinical implications.

Authors:  Annemiek Vermeeren
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 6.  Biomarkers for the effects of benzodiazepines in healthy volunteers.

Authors:  S J de Visser; J P van der Post; P P de Waal; F Cornet; A F Cohen; J M A van Gerven
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335

7.  Acute and subacute effects on psychomotor performance of femoxetine alone and with alcohol.

Authors:  C Strömberg; M J Mattila
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

8.  Effects of zimeldine, mianserin and amitriptyline on psychomotor skills and their interaction with ethanol a placebo controlled cross-over study.

Authors:  T Seppälä; C Strömberg; I Bergman
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

9.  Objective and subjective assessment of hangover during subacute administration of temazepam and nitrazepam to healthy subjects.

Authors:  M J Mattila; K Aranko; M E Mattila; C Strömberg
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

10.  Acute and subchronic effects of Org 2305 and diazepam on psychomotor performance in man.

Authors:  M J Mattila; J Koski; C Strömberg
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.